ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women’s health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising £192,244. Also issues 499,998 new shares via a subscription. In total, raises £1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Current stock price: 6.09 pence, down 1.8%

12-month change: down 53%

Copyright 2023 Alliance News Ltd. All Rights Reserved.